1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Plant-Based Investment Corp.

Plant-Based Investment Corp.

CWWBF
Plant-Based Investment Corp.US flagOther OTC
0.00
USD
- -
- -
275.00Market Cap
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
TTM
Revenue per Share
- -
0.51
-0.07
-0.58
-0.13
-0.77
Basic EPS, GAAP
- -
0.29
-0.18
-0.66
-0.29
-0.82
Free Cash Flow per Basic Share
- -
-3.04
0.06
- -
-0.08
0.01
Dividend per Share
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
2.61
1.85
0.9
0.43
0.05
Tangible Book Value per Share
- -
3.49
2.52
1.39
0.83
0.44
Basic Weighted Avg Shares
16
12
16
22
27
28
Sales/Revenue/Turnover
- -
6
-1
-13
-4
-21
Operating Margin (%)
- -
57
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
3
-3
-15
-8
-23
Effective Tax Rate (%)
- -
0.09
- -
- -
- -
- -
Profit Margin (%)
- -
56.94
248.03
112.88
220.18
106.52
Working Capital
- -
42
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
Total Equity
- -
41
39
31
23
12
Return on Invested Capital (%)
- -
16.51
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
22.46
-9.61
-59.7
-49.21
-177.74

Capital Structure

FRC

•

in mil. unless spec.
Jan'22
Apr'22
Jul'22
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
28
28
28
Market Capitalization
6
6
3

Working Capital

FRC

•

in mil. unless spec.
Jan'22
Apr'22
Jul'22
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-26.7%
Free Cash Flow
- -
- -
2,490.81%
Net Income, GAAP
- -
- -
-46.62%
Sales/Revenue/Turnover
- -
- -
-72.63%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
-3
-11
4
-3
-13
2021
13
3
-8
-12
-4
2022
-1
-4
-4
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
-0.19
-0.49
0.13
- -
-0.66
2021
0.47
0.08
-0.35
- -
-0.29
2022
-0.06
-0.17
-0.15
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Paul Jason Crath
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
240 Richmond Street West Toronto ON Canada M5V 1V6
IPO Date
Mar 2, 2018
Website
pbinvest.ca
Similar Companies
Toleranzia AB (TOL.ST)
North China Pharmaceutical Company Ltd. (600812.SS)
Emcure Pharmaceuticals Ltd. (EMCURE.NS)
Flower One Holdings Inc. (FLOOF)
BioELife Corp. (LITH)
Lobe Sciences Ltd. (LOBEF)
Business
Plant-Based Investment Corp. (CSE:PBIC, OTC:CWWBF) operates as a principal investment firm focused on the cannabis industry; it invests in public and private companies deriving revenues, earnings, or intellectual property value from plant-based sectors including the cannabis plant family and its compounds such as CBD, CBG, and CBN, hemp plants, terpenes, flavonoids, fungi encompassing medicinal, functional, and psychedelic varieties, superfoods, organic ingredients, specialty retail locations, functional medicine, and wellness clinics or treatment centers. The firm, formerly known as Cannabis Growth Opportunity Corp., was founded in 2017 and maintains headquarters in Toronto, Ontario, Canada; it primarily serves shareholders seeking long-term total returns through capital appreciation via an actively managed portfolio generated using fundamental analysis, bottom-up, and top-down stock picking approaches. Geographically, it targets opportunities in North America with holdings in public cannabis companies and related private entities. In recent developments, the company entered Companies' Creditors Arrangement Act proceedings in May 2023 amid filing delays for its 2022 annual financial statements, faced a management cease trade order in March 2023, saw director resignations including Sean Conacher in April 2023, and had its shares delisted from the Canadian Securities Exchange in June 2023; earlier, it completed the acquisition of CGOC Management Corp. in May 2022 and shifted strategic emphasis from active investing by declaring itself no longer investing as a principal firm.

Company News

APIChatGPT

  • accesswire.com

    PBIC Provides Update on Previously Announced Non-Brokered Private Placement

  • accesswire.com

    PBIC Announces Investment in Aion Therapeutic Inc.